Viking Therapeutics (VKTX) News Today $27.18 +0.20 (+0.74%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$27.24 +0.05 (+0.20%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VKTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Woodline Partners LP Raises Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Woodline Partners LP raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 93,294 shares of the biotechnology companMay 27 at 4:37 AM | marketbeat.comWaverly Advisors LLC Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Waverly Advisors LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 34.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,369 shares of the biotechnology company'May 25 at 4:41 AM | marketbeat.comCastleark Management LLC Trims Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Castleark Management LLC lessened its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,978 shares of the biotechnology company's stock aftMay 24, 2025 | marketbeat.comBank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Bank of America Corp DE lowered its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 14.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 361,551 shares of the biotechnology company's stockMay 24, 2025 | marketbeat.comViking Therapeutics: Weight-Loss Story Remains IntactMay 22, 2025 | seekingalpha.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Reduces Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. reduced its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 45.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 267,464 shares of the bioMay 22, 2025 | marketbeat.comViking Therapeutics: A High Potential Biotech Play With Manageable RisksMay 20, 2025 | seekingalpha.comViking Therapeutics: Near-Term Catalysts And Competitor ReadoutsMay 20, 2025 | seekingalpha.comTang Capital Management LLC Grows Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Tang Capital Management LLC lifted its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 166.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 320,000 shares of the biotechnology company's stMay 20, 2025 | marketbeat.comTema Etfs LLC Invests $813,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)Tema Etfs LLC bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 20,215 shares of the biotechnology company's stock, valued at approximatelyMay 20, 2025 | marketbeat.comRaiffeisen Bank International AG Invests $477,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)Raiffeisen Bank International AG bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 12,000 shares of the biotechnology company's stock, valued at approMay 20, 2025 | marketbeat.comBNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)BNP Paribas Financial Markets lessened its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 46,701 shares of the biotechnology company's stock after selling 40,011 shares duringMay 20, 2025 | marketbeat.comSecond Line Capital LLC Purchases 11,393 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Second Line Capital LLC boosted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 49,511 shares of the biotechnology company's stMay 19, 2025 | marketbeat.comRafferty Asset Management LLC Has $10.91 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)Rafferty Asset Management LLC boosted its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 6.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 271,163 shares of the biotechnology companyMay 19, 2025 | marketbeat.comMan Group plc Boosts Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Man Group plc lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 3,373.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 448,732 shares of the biotechnology company's stockMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Has $4.16 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Sphera Funds Management LTD. lowered its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 22.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 103,270 shares of the biotechnology company's stock afterMay 18, 2025 | marketbeat.comWhy Viking Therapeutics Stock Bumped 3% Higher TodayMay 16, 2025 | fool.comNorthern Trust Corp Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Northern Trust Corp increased its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,984 shares of the biotechnology company'sMay 15, 2025 | marketbeat.comDimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Dimensional Fund Advisors LP lowered its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 100,762 shares of the biotechnology company's stock after selling 10,394 shares durMay 15, 2025 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)May 14, 2025 | theglobeandmail.comIntegral Health Asset Management LLC Sells 100,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Integral Health Asset Management LLC reduced its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 40.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 150,000 shares of the biotechnology companyMay 14, 2025 | marketbeat.comEnsign Peak Advisors Inc Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Ensign Peak Advisors Inc decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 412,656 shares of the bMay 14, 2025 | marketbeat.com2 Monster Stocks in the Making to Buy Now and Hold for 10 YearsMay 13, 2025 | msn.comAmeriprise Financial Inc. Has $59.54 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Ameriprise Financial Inc. increased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 228.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,479,596 shares of the biotechnology compMay 13, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Buy" by AnalystsShares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) have received a consensus rating of "Buy" from the fourteen ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two hMay 13, 2025 | marketbeat.comGranahan Investment Management LLC Has $12.30 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Granahan Investment Management LLC trimmed its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 6.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 305,586 shares of the biotechnology company's stock after selling 19,701 sharesMay 12, 2025 | marketbeat.comFORA Capital LLC Makes New $1.12 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)FORA Capital LLC acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,744 shares of the biotechnology company's stMay 12, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Fred Alger Management LLCFred Alger Management LLC decreased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,569 shares of the biotechnologMay 12, 2025 | marketbeat.comHsbc Holdings PLC Sells 9,437 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Hsbc Holdings PLC reduced its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 61.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,849 shares of the biotechnology company's stock after selling 9,43May 12, 2025 | marketbeat.com3 Monster Stocks in the MakingMay 11, 2025 | fool.comFrontier Capital Management Co. LLC Purchases 16,321 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Frontier Capital Management Co. LLC lifted its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 597,739 shares of the biotechnologMay 11, 2025 | marketbeat.comComerica Bank Reduces Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Comerica Bank decreased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 69.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,061 shares of the biotechnology company's stock afterMay 11, 2025 | marketbeat.comDAFNA Capital Management LLC Lowers Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)DAFNA Capital Management LLC trimmed its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 48.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,516 shares of the biotecMay 10, 2025 | marketbeat.comBoone Capital Management LLC Boosts Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Boone Capital Management LLC raised its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 209,853 shares of the biotechnology compaMay 8, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Position Lifted by Braidwell LPBraidwell LP grew its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 27.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,479,666 shares of the biotechnology company's stock after purchasing an aMay 8, 2025 | marketbeat.comAptus Capital Advisors LLC Purchases 10,564 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Aptus Capital Advisors LLC lifted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 27.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,707 shares of the biotechnology company's stMay 8, 2025 | marketbeat.comCantor Fitzgerald L. P. Takes $380,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Cantor Fitzgerald L. P. bought a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 9,450 shares of the biotechnoMay 7, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Bamco Inc. NYBamco Inc. NY decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 18.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 385,472 shares of the biotechnology company's stocMay 7, 2025 | marketbeat.comAQR Capital Management LLC Boosts Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)AQR Capital Management LLC increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 15.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 537,239 shares of the biotechnolMay 6, 2025 | marketbeat.comWhy Viking Therapeutics Stock Surged Nearly 20% Higher in AprilMay 6, 2025 | fool.comApis Capital Advisors LLC Has $3.86 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Apis Capital Advisors LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 24.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 96,000 shares of the biotechnology company's stock afteMay 5, 2025 | marketbeat.com5AM Venture Management LLC Has $7.63 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)5AM Venture Management LLC cut its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 20.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 189,593 shares of the biotMay 4, 2025 | marketbeat.com683 Capital Management LLC Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)683 Capital Management LLC reduced its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 12.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 280,000 shares of the biotechnology compMay 4, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by MML Investors Services LLCMML Investors Services LLC increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 45.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,673 shares of the biotechnoloMay 4, 2025 | marketbeat.comResearch Analysts Set Expectations for VKTX FY2025 EarningsViking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Viking Therapeutics in a research report issued on Tuesday, April 29th. Cantor Fitzgerald analyst S. Seedhouse forecasts that the biotechnology companyMay 3, 2025 | marketbeat.comViking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025May 3, 2025 | finance.yahoo.comWhy Viking Therapeutics Stock Was Victorious This WeekMay 2, 2025 | fool.comWhy Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped FridayMay 2, 2025 | fool.comViking Therapeutics (NASDAQ:VKTX) Raised to "Strong-Buy" at Cantor FitzgeraldCantor Fitzgerald upgraded Viking Therapeutics to a "strong-buy" rating in a report on Tuesday.May 2, 2025 | marketbeat.comWhere Will Viking Therapeutics Be in 3 Years?May 2, 2025 | fool.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼1.491.03▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼716▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Viatris News Today Qiagen News Today Roivant Sciences News Today Revolution Medicines News Today Blueprint Medicines News Today BridgeBio Pharma News Today Elanco Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VKTX Stock Free VKTX Stock Alerts